Androski Lindsay
Insider CIK 1936604 · ELOX Director · ABUS President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABUS Arbutus Biopharma Corp | D To issuer | 2026-10-01 | 2026-10-07 | 24,655 | $5.00 | $123.3K | 47,682 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 116,408 | — | $0 | 194,014 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 10,456 | — | $0 | 61,244 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 10,456 | $4.39 | $45.9K | 154,864 | SEC↗ |
| ABUS Arbutus Biopharma Corp | F Tax w/h | 2026-09-18 | 2026-09-23 | 82,527 | $5.07 | $418.4K | 72,337 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 116,408 | $3.20 | $372.5K | 144,408 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 10,456 | — | $0 | 61,244 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 116,408 | — | $0 | 194,014 | SEC↗ |
| ABUS Arbutus Biopharma Corp | F Tax w/h | 2026-09-18 | 2026-09-23 | 82,527 | $5.07 | $418.4K | 72,337 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 10,456 | $4.39 | $45.9K | 154,864 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 116,408 | $3.20 | $372.5K | 144,408 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2026-02-02 | 2026-02-02 | 71,700 | — | $0 | 71,700 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award | 2026-02-02 | 2026-02-02 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2025-03-18 | 2025-03-20 | 310,422 | — | $0 | 310,422 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2025-01-24 | 2025-01-28 | 3,750 | — | $0 | 3,750 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise | 2025-01-24 | 2025-01-28 | 3,750 | — | $0 | 15,750 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award | 2024-10-16 | 2024-10-17 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2024-01-24 | 2024-01-26 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2023-01-30 | 2023-01-31 | 2,859 | — | $0 | 2,859 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2022-07-01 | 2022-07-06 | 40,000 | — | $0 | 40,000 | SEC↗ |